EUVIMEDEUVIMED entdecken
Crossref

Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats

Hongjie Yang, Jun Zhu, Hui Fu, Wei Shuai

Heart, Lung and Circulation · 2024-01 · 33 (1) · 65-77

DOI: 10.1016/j.hlc.2023.09.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2024-01. Verfasst von Hongjie Yang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure, Nitriles, Sulfones. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Numerous studies have demonstrated that NLRP3 inflammasomes are key players in the progression of atrial fibrillation (AF) in heart failure with preserved ejection fraction (HFpEF). This study aimed to analyse the effect of pharmacological inhibition of NLRP3 inflammasomes using dapansutrile (DAPA), an oral NLRP3-specific inhibitor. METHODS: Dahl salt-sensitive rats were fed a high-salt diet (HSD, 8% NaCl) to induce HFpEF. Either DAPA (200 mg/kg/day) or saline was administered daily via gavage for 4 weeks. Electrophysiological studies were performed to assess the AF inducibility. Confocal fluorescence microscopy and western blot analysis were used to study calcium handling. RESULTS: The DAPA-treated HFpEF rats were less prone to AF induction by programmed electrical stimulation. Atrial fibrosis and inflammation were attenuated in DAPA-treated HFpEF hearts. Dapansutrile treatment showed an increase in the Ca2+ transient sarcoplasmic reticulum-Ca2+ load, and protein expression of SERCA2; NCX1 and phosphorylation of PLB at Thr17 were decreased following DAPA treatment. The increased frequency of spontaneous Ca2+ spark in the HFpEF rats was related to the hyperphosphorylation of RyR2 at Ser2814, which was blunted in DAPA treatment. Dapansutrile treatment also decreased the phosphorylation of CaMKII expression in the HFpEF rats. Mechanistically, DAPA exerts an anti-arrhythmic effect, mainly by inhibiting activation of the NLRP3 inflammasome. CONCLUSION: These data provide evidence that the beneficial cardiac effects of DAPA are associated with reduced atrial inflammation and improved CaMKII-dependent Ca2+-handling abnormalities via blunting activation of the NLRP3 inflammasome, and DAPA may be beneficial in a rat model of HFpEF-induced AF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureNitrilesSulfonesRatsAnimalsNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesStroke VolumeCalcium-Calmodulin-Dependent Protein Kinase Type 2Rats, Inbred DahlHeart AtriaInflammation

Stichwörter der Autor:innen

Atrial fibrillationCalcium handlingHeart failure with preserved ejection fractionNLRP3 inflammasome

Substanzen

dapansutrileNLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesCalcium-Calmodulin-Dependent Protein Kinase Type 2NitrilesSulfones

Autor:innen und Institutionen

  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China.
  • Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; Cardiovascular Research Institute, Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China. Electronic address: sw091…

Förderung

  • Natural Science Foundation of Hubei Province
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yang, H., Zhu, J., Fu, H., & Shuai, W. (2024). Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats. Heart, Lung and Circulation, 33(1), 65-77. https://doi.org/10.1016/j.hlc.2023.09.017

Vancouver

Yang H, Zhu J, Fu H, Shuai W. Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats. Heart, Lung and Circulation. 2024;33(1):65-77. doi:10.1016/j.hlc.2023.09.017

BibTeX
@article{Yang2024,
  author = {Yang, Hongjie and Zhu, Jun and Fu, Hui and Shuai, Wei},
  title = {Dapansutrile Ameliorates Atrial Inflammation and Vulnerability to Atrial Fibrillation in HFpEF Rats},
  journal = {Heart, Lung and Circulation},
  year = {2024},
  volume = {33},
  number = {1},
  pages = {65--77},
  doi = {10.1016/j.hlc.2023.09.017}
}
Kostenlos starten →